Cytosorbents

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO

Phillip P. Chan

CEOPhillip P. Chan

Employees

149

Employees149

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1997

Founded1997

Employees

149

Employees149

CTSO Key Statistics

Market cap

80.45M

Market cap80.45M

Price-Earnings ratio

-4.49

Price-Earnings ratio-4.49

Dividend yield

—

Dividend yield—

Average volume

127.93K

Average volume127.93K

High today

$1.30

High today$1.30

Low today

$1.25

Low today$1.25

Open price

$1.27

Open price$1.27

Volume

56.41K

Volume56.41K

52 Week high

$1.61

52 Week high$1.61

52 Week low

$0.7101

52 Week low$0.7101

People also own

Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.